Bio-Sourcing

Bio-Sourcing utilizes a proprietary technological platform to produce biopharmaceuticals, specifically monoclonal antibodies, in the milk of specialized goats. By combining CRISPR-Cas9 gene editing with nuclear transfer and reproductive technologies, the company creates natural bioreactors that offer a lower carbon footprint and reduced production costs compared to traditional steel-tank methods. The company targets global health needs by providing scalable and affordable biotherapeutic solutions for both Western and emerging markets.